Liver (Neoplasia HCC)

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Liver (Neoplasia HCC).php on line 2
Liver (Neoplasia HCC)

LE WE PMID CA

Liver (Neoplasia HCC)

12235

Leber (Neubildung HCC)

alpha Fetoprotein

Autoantibodies Profiling

Bone (Metastasis)

Epigenetics

Ferroportin

Glypican3

Hepatitis B

Liver (MRT)

Liver (Neoplasia HCC)

Liver (Steatohepatosis)

MAT1A methhionine adenosyltransferase

MAT2A methionine adenosyltransferase

MAT2beta methionine adenosyltransferase

Myc

Neoplasia (Radiofrequency ablation)

S Adenosyl methionine

Sorafenib

Stem cell (Neoplasia)

2010 1	Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. [20887318] HPB (Oxford) 12(8): 509-22 (2010)
2011 2	A survey on herbal management of hepatocellular carcinoma. [21866249] World J Hepatol 3(7): 175-83 (2011)
2010 3	Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib. [21160981] World J Hepatol 2(3): 103-13 (2010)
2010 4	Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma. [21160982] World J Hepatol 2(3): 114-26 (2010)
2010 5	Targeting c-Myc as a novel approach for hepatocellular carcinoma. [21160952] World J Hepatol 2(1): 16-20 (2010)
2010 6	Current status of radiofrequency ablation of hepatocellular carcinoma. [21160861] World J Gastrointest Surg 2(4): 128-36 (2010)
2010 7	Radiofrequency ablation of hepatocellular carcinoma: pros and cons. [21103289] Gut Liver 4 Suppl 1(-): S113-8 (2010)
2010 8	Is percutaneous ethanol injection therapy still effective for hepatocellular carcinoma in the era of radiofrequency ablation? [21103288] Gut Liver 4 Suppl 1(-): S105-12 (2010)
2009 9	Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma. [19432967] BMC Gastroenterol 9(-): 31 (2009)
2010 10	Cancer gene discovery in hepatocellular carcinoma. [20385424] J Hepatol 52(6): 921-9 (2010)
2008 11	Experimental models of hepatocellular carcinoma. [18314222] J Hepatol 48(5): 858-79 (2008)
2011 12	Surgical treatment for hepatocellular carcinoma. [21411469] Jpn J Clin Oncol 41(4): 447-54 (2011)
2011 13	Radiofrequency ablation of hepatocellular carcinoma: a literature review. [21994847] Int J Hepatol 2011(-): 104685 (2011)
2011 14	Targeted therapy in hepatocellular carcinoma. [21994852] Int J Hepatol 2011(-): 348297 (2011)
2011 15	Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians. [21994860] Int J Hepatol 2011(-): 489342 (2011)
2009 16	Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. [19141028] Liver Int 29(4): 502-10 (2009)
2009 17	Prognostic scores for hepatocellular carcinoma: none is the winner. [19323777] Liver Int 29(4): 478-80 (2009)
2007 18	Bone metastasis from primary hepatocellular carcinoma: characteristics of soft tissue formation. [19746218] Cancer Res Treat 39(3): 104-8 (2007)
2008 19	S-Adenosylmethionine in cell growth, apoptosis and liver cancer. [18336669] J Gastroenterol Hepatol 23 Suppl 1(-): S73-7 (2008)
2008 20	Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review. [19669276] Hepatol Int 2(1): 17-30 (2008)
2011 21	Sorafenib for advanced hepatocellular carcinoma: a systematic review. [21375938] Zhongguo Yi Xue Ke Xue Yuan Xue Bao 33(1): 51-7 (2011)
2011 22	Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics. [21428856] Clin Chem Lab Med 49(6): 959-66 (2011)
2011 23	Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. [21966251] Curr Genomics 12(2): 130-7 (2011)
2007 24	Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma. [17289549] Autoimmun Rev 6(3): 143-8 (2007)
2011 25	Impact of hepatitis B virus (HBV) x gene mutations on hepatocellular carcinoma development in chronic HBV infection. [21490166] Clin Vaccine Immunol 18(6): 914-21 (2011)
PMC 26	Ferroportin in the progression and prognosis of hepatocellular carcinoma. [24360312] Eur J Med Res 18():59 (2013)
PMC 27	Epidemiology and prognosis of paraneoplastic syndromes in hepatocellular carcinoma. [24396608] ISRN Oncol 2013():684026 (2013)
PMC 28	From cirrhosis to hepatocellular carcinoma: new molecular insights on inflammation and cellular senescence. [24400224] Liver Cancer 2(3-4):367-83 (2013)
PMC 29	Clinical trials in hepatocellular carcinoma: an update. [24400222] Liver Cancer 2(3-4):345-64 (2013)
PMC 30	Alpha-fetoprotein-L3: Useful or Useless for Hepatocellular Carcinoma? [24400219] Liver Cancer 2(3-4):151-2 (2013)
PMC 31	Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis. [24415867] World J Gastroenterol 20(1):142-7 (2014)
PMC 32	Transplant benefit for patients with hepatocellular carcinoma. [24409046] World J Gastroenterol 19(48):9183-8 (2013)
PMC 33	Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis. [24409045] World J Gastroenterol 19(48):9174-82 (2013)
PMC 34	Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma. [24495509] BMC Cancer 14():65 (2014)
PMC 35	Nonsurgical treatment for localized hepatocellular carcinoma. [24488546] Curr Oncol Rep 16(3):373 (2014)
PMC 36	Comparison of high-intensity focused ultrasound therapy and radiofrequency ablation for recurrent hepatocellular carcinoma. [24570937] Hepatobiliary Surg Nutr 2(3):168-70 (2013)
PMC 37	Liver transplantation for hepatocellular carcinoma. [24570911] Hepatobiliary Surg Nutr 2(1):22-30 (2013)
PMC 38	High-intensity focused ultrasound (HIFU) for the treatment of hepatocellular carcinoma: is it time to abandon standard ablative percutaneous treatments? [24570943] Hepatobiliary Surg Nutr 2(4):184-7 (2013)
PMC 39	Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation. [24570921] Hepatobiliary Surg Nutr 2(2):84-8 (2013)
PMC 40	Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model. [24586728] PLoS One 9(2):e89373 (2014)
PMC 41	Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring. [24006223] Tumour Biol 35(1):9-20 (2014)
PMC 42	Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound. [24578787] World J Radiol 6(1):7-14 (2014)
PMC 43	Radiofrequency ablation compared to resection in early-stage hepatocellular carcinoma. [23374361] HPB (Oxford) 15(3):210-7 (2013)
PMC 44	Combining locoregional therapies in the treatment of hepatocellular carcinoma. [24436520] Semin Intervent Radiol 30(1):74-81 (2013)
PMC 45	Chemoembolization of hepatocellular carcinoma. [24436512] Semin Intervent Radiol 30(1):3-11 (2013)
PMC 46	Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort. [24609114] PLoS One 9(3):e88182 (2014)
PMC 47	Clinical value of circulating liver cancer cells for the diagnosis of hepatocellular carcinoma: A meta-analysis. [24649019] Biomed Rep 1(5):731-736 (2013)
PMC 48	Newer treatments for advanced hepatocellular carcinoma. [24648795] Korean J Intern Med 29(2):149-55 (2014)
PMC 49	Tumor markers for hepatocellular carcinoma. [24649215] Mol Clin Oncol 1(4):593-598 (2013)
PMC 50	Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis. [24659894] World J Gastroenterol 20(11):3025-32 (2014)
PMC 51	Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma. [24672660] Gut Liver 8(2):177-85 (2014)
PMC 52	The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrence. [24713719] Ann Gastroenterol 24(3):228-230 (2011)
PMC 53	Clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-B non-C hepatocellular carcinoma patients with comparison to hepatitis B or C virus. [24745029] Biomed Res Int 2014():975380 (2014)
PMC 54	Nonalcoholic fatty liver disease and hepatocellular carcinoma. [24738043] Biomed Res Int 2014():106247 (2014)
PMC 55	Interventional therapies for hepatocellular carcinoma. [22487698] Cancer Imaging 12():79-88 (2012)
PMC 56	Use of statins in hepatocellular carcinoma. [24719599] Gastroenterol Hepatol (N Y) 9(8):512-4 (2013)
PMC 57	Tumor factors associated with clinical outcomes in patients with hepatitis B virus infection and hepatocellular carcinoma. [24693270] Gastroenterol Hepatol (N Y) 8(12):808-19 (2012)
PMC 58	Clinical characteristics and surgical prognosis of hepatocellular carcinoma with bile duct invasion. [24723944] Gastroenterol Res Pract 2014():604971 (2014)
PMC 59	Antiangiogenic therapies for advanced hepatocellular carcinoma. [23576483] Oncologist 18(4):430-8 (2013)
PMC 60	Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI. [24764654] World J Gastroenterol 20(15):4160-6 (2014)
PMC 61	Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age. [24764653] World J Gastroenterol 20(15):4151-9 (2014)
PMC 62	Staging systems of hepatocellular carcinoma: a review of literature. [24764652] World J Gastroenterol 20(15):4141-50 (2014)
PMC 63	Hepatocellular carcinoma review: current treatment, and evidence-based medicine. [24764650] World J Gastroenterol 20(15):4115-27 (2014)
PMC 64	Propensity score analysis demonstrated the prognostic advantage of anatomical liver resection in hepatocellular carcinoma. [24696614] World J Gastroenterol 20(12):3335-42 (2014)
PMC 65	Development of systemic therapy for hepatocellular carcinoma at 2013: updates and insights. [24696599] World J Gastroenterol 20(12):3135-45 (2014)
PMC 66	Role of stereotactic body radiation therapy for hepatocellular carcinoma. [24696597] World J Gastroenterol 20(12):3100-11 (2014)
PMC 67	Systemic therapy of hepatocellular carcinoma: current status and future perspectives. [24696596] World J Gastroenterol 20(12):3087-99 (2014)
PMC 68	New approaches for precise response evaluation in hepatocellular carcinoma. [24696594] World J Gastroenterol 20(12):3059-68 (2014)
PMC 69	Transarterial chemoembolization and bland embolization for hepatocellular carcinoma. [24695579] World J Gastroenterol 20(12):3069-77 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Liver (Neoplasia HCC).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Liver (Neoplasia HCC).php on line 92